Posted in | News

Cree and Nichia Corporation in Patent Cross LIcencing Agreement

Feb 11 2005

Related Stories

Cree, Inc. today announced that it has entered into a patent cross license agreement with Nichia Corporation relating to LED technology for solid-state white lighting. The new agreement complements the patent cross license arrangement between the companies announced in November 2002. Detailed terms of the agreement were not disclosed.

Chuck Swoboda, Cree's President and CEO stated, “Nichia has developed pioneering technology in the field of LED-based white lighting and this agreement gives Cree access to this important technology. At the same time, the agreement recognizes the strength of Cree’s intellectual property and reinforces both companies’ leadership in solid-state lighting."

For more infromation on lighting click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback